Cafepharma Today

February 6 2025 - Bristol Myers Squibb tops Q4 estimates
Bristol Myers Squibb tops Q4 estimates
AstraZeneca bounds higher on Q4 beat, upbeat guidance
Novo Nordisk says it's not immune to potential Trump tariffs, but business is well-positioned
Pfizer taps a former Novartis exec to lead cancer drug push
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Cephalon: seeking more legitimate patients for Provigil follow-on
Pharmaceutical Business Review
Tuesday, March 24, 2009 - 7:27am
tags:
Provigil, Cephalon, drug trials, bipolar disorder
Biogen Tests Malaria Drug as Cure for Tysabri Brain Infection
Bloomberg
Tuesday, March 24, 2009 - 6:09am
tags:
Biogen Idec, Tysabri, Elan, PML
Reports: Swiss drugmaker Nycomed is up for sale
Marketwatch
Tuesday, March 24, 2009 - 6:07am
tags:
Nycomed, Sanofi, Merck, Eli Lilly
AstraZeneca: Another Case of How Big Pharma Shouldn't Handle Clinical Data
Seeking Alpha
Tuesday, March 24, 2009 - 6:06am
tags:
AstraZeneca, Seroquel
Doctors increasingly close doors to drug reps, while pharma cuts ranks
American Medical News
Monday, March 23, 2009 - 8:55pm
tags:
doctors, drug reps, physician access
Bayer, Biotin eye Chinese insulin market
Fierce Pharma
Monday, March 23, 2009 - 8:54pm
tags:
Bayer, China, insulin, diabetes, Biotin
Good News for Eli Lilly's Depression Drug
Motley Fool
Monday, March 23, 2009 - 8:52pm
tags:
Eli Lilly, antidepressants, Symbyax, Zyprexa, Prozac
Genentech & Abbott CEOs Roar
CNBC
Monday, March 23, 2009 - 7:42pm
tags:
Pharma CEOs, Genentech, Abbott Laboratories
Allergan Call-Buying Surges, Options Show
TheStreet.com
Monday, March 23, 2009 - 7:37pm
tags:
Allergan, options
Merck says it's "target" of federal Vioxx probe
Yahoo/AP
Monday, March 23, 2009 - 7:36pm
tags:
Vioxx, Merck
Which Pharmas Still Have Cash?
Motley Fool
Monday, March 23, 2009 - 7:33pm
tags:
pharma industry, GSK, Merck, Pfizer, JNJ, Quest Diagnostics, Wyeth, Myriad Genetics, Novartis, Bristol-Myers Squibb
Amylin Looks Range-Bound
Yahoo/Zacks.com
Monday, March 23, 2009 - 7:32pm
tags:
Amylin, Byetta, Eli Lilly
The Long Decline of Drug Sales Reps
WSJ Online
Monday, March 23, 2009 - 11:58am
tags:
drug reps, layoffs
Roche reports positive results from gastric cancer study
Pharmaceutical Business Review
Monday, March 23, 2009 - 11:15am
tags:
Roche, cancer, Herceptin
Top Three 2009 Biotech Stock Picks
TheStreet.com
Monday, March 23, 2009 - 11:08am
tags:
biotech, Gilead Sciences, Biomarin, Amag Pharmaceuticals
Teva: What's Next for the 'Generic Giant'?
Seeking Alpha
Monday, March 23, 2009 - 11:07am
tags:
Teva Pharmaceuticals, generics, Barr Laboratories
Endo Pharmaceuticals' Growth Story
Seeking Alpha
Monday, March 23, 2009 - 11:06am
tags:
Endo, generics
Obesity Drug Arena's Heavy Burden
TheStreet.com
Monday, March 23, 2009 - 9:42am
tags:
obesity, Arena Pharmaceuticals, Vivus, fen phen, Orexigen, Wyeth, lorcaserin
German Merck launches biotech venture capital fund
Yahoo/AP
Monday, March 23, 2009 - 9:41am
tags:
Merck KGaA, venture capital
Eli Lilly gets expanded FDA approval on Symbyax
Yahoo/AP
Monday, March 23, 2009 - 9:40am
tags:
Eli Lilly, FDA, Symbyax, depression

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Revised and Extended: What's Happening Inside the NIH and NSF
In the Pipeline
What's Happening Inside the NIH and NSF
In the Pipeline
Vertical Integration Redux: How Pharmaceutical Wholesalers Are Transforming the Buy-and-Bill Market (Video)
Drug Channels
Informa Connect's Access USA
Drug Channels
Fresh Asteroid, Getcher Fresh Asteroid Here
In the Pipeline
Unlocking AI’s Promise in Patient Support Programs
Drug Channels
Right There At the Electrode
In the Pipeline
Annoying Enzyme Activity
In the Pipeline
Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels

Latest Jobs

Cell Therapy Navigator
Houston, Texas, 77002
Inizio Engage
Rapid Deployment Representative
Fort Worth, Texas, 76102
Inizio Engage
Rapid Deployment Representative
Charlotte, North Carolina, 28245
Inizio Engage
Oncology Key Account Manager
Newark, New Jersey, 07175
Inizio Engage
Cell Therapy Navigator
Little Rock, Arkansas, 72208
Inizio Engage
Territory Business Manager
Philadelphia, Pennsylvania, 19107
Inizio Engage
Business Development Representative
Las Vegas, Nevada, 89105
Professional Case Management
Oncology Key Account Manager
Atlanta, Georgia, 30383
Inizio Engage
Territory Manager, Surgical Pain - South Houston, TX
TX,
Avanos Medical
Neurology Account Manager- MD/DC/N VA (Remote)
Annapolis, Maryland, 21401
Jazz Pharmaceuticals
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information